The Journal of Allergy and Clinical Immunology
Volume 116, Issue 2 , Pages 279-284 , August 2005

Is it traffic type, volume, or distance? Wheezing in infants living near truck and bus traffic

  • Patrick H. Ryan, MS

      Affiliations

    • From the Department of Environmental Health
    • Corresponding Author InformationReprint requests: Patrick H. Ryan, MS, Department of Environmental Health, University of Cincinnati, Cincinnati, OH 45267-0056.
    • ,
  • Grace LeMasters, PhD

      Affiliations

    • From the Department of Environmental Health
    • ,
  • Jocelyn Biagini, MS

      Affiliations

    • From the Department of Environmental Health
    • ,
  • David Bernstein, MD

      Affiliations

    • Department of Internal Medicine, Division of Immunology, University of Cincinnati
    • ,
  • Sergey A. Grinshpun, PhD

      Affiliations

    • From the Department of Environmental Health
    • ,
  • Rakesh Shukla, PhD

      Affiliations

    • From the Department of Environmental Health
    • ,
  • Kimberly Wilson, MS

      Affiliations

    • From the Department of Environmental Health
    • ,
  • Manuel Villareal, MD

      Affiliations

    • Department of Internal Medicine, Division of Immunology, University of Cincinnati
    • ,
  • Jeff Burkle, BS

      Affiliations

    • From the Department of Environmental Health
    • ,
  • James Lockey, MD

      Affiliations

    • From the Department of Environmental Health

Received 15 March 2005 ,Revised 9 May 2005 ,Accepted 10 May 2005.

  • Image Result

    Prevalence of wheeze (without cold) among infants within exposure categories by distance from the nearest DEP source. SR, State route; BR, bus route; HW, highway.

    Prevalence of wheeze (without cold) among infants within exposure categories by distance from the nearest DEP source. SR, State route; BR, bus route; HW, highway.

  • Image Result

    Prevalence of wheeze (without cold) among infants stratified by race.

    Prevalence of wheeze (without cold) among infants stratified by race.

 Supported by grants ES11170 and ES10957 from the National Institute of Environmental Health Sciences.Disclosure of potential conflict of interest: S. A. Grinshpun has received grants–research support from the National Institute of Environmental Health Sciences. M. Villareal has consultant arrangements with Aventis, has stock or other equity ownership with Pfizer, and is on the speakers' bureaus for AstraZeneca, UCB Pharma, Pfizer, Aventis, and GlaxoSmithKline. There are not other potential conflicts to disclose.

PII: S0091-6749(05)01309-6

doi: 10.1016/j.jaci.2005.05.014

The Journal of Allergy and Clinical Immunology
Volume 116, Issue 2 , Pages 279-284 , August 2005

Article Tools

* Image Usage & Resolution